RE:Trying to wrap my head around CXR current SPAll pharmas have been knocked down several fold by misinformation coming from a well organized short and distort campaign by unscrupulous newsletter writers paid by hedge funds who worked as wolf packs.
It is tethered in illegality but the SEC treats it as normal due diligence which it isn't.
Canadian pharmas took the largest hits.
All of these pharmas are now in strong rebound towards former high.
Concordia has been in greatest contradiction to its asset value, as AMco closed in the middle of the distortion event.
An appropriate comparison might be Horizon ( HZNP).
It has only about a dozen drugs .
It trades at 2.5 times Concordia's price to sales and about 3 times its price to earnings.
Recognition of Concordia's transformation has yet to be seen in its market cap.
As conviction returns to this sector, Concordia should not take only regain its former highs but exceed them , as the full suite of acquired drugs enter commercial status